Related Experiment Videos
Current and future therapy in muscular dystrophy; need for a common language between basic scientists and clinicians
Summary
Current Duchenne muscular dystrophy treatments include orthoses and corticosteroids. Future therapies may involve cell and gene therapy, but clearer scientific language and animal models are needed for progress.
Area of Science:
- Neurology
- Genetics
- Biomedical Research
Background:
- Reviews current Duchenne muscular dystrophy (DMD) therapies, including knee-ankle-foot orthoses and corticosteroids for ambulation.
- Highlights ongoing research in cell therapy, gene therapy, protein upregulation, and pharmacology for future DMD applications.
Discussion:
- Critiques inappropriate nomenclature and the need for standardized terminology between basic and clinical scientists.
- Addresses issues with equating the mdx mouse model to human DMD and the use of emotive terms like 'rescue' or 'reversal'.
- Discusses the misapplication of 'therapy' for experimental procedures in basic and clinical studies.
Key Insights:
- Current effective DMD treatments focus on prolonging ambulation and managing symptoms.
- Significant research is underway exploring novel therapeutic strategies for DMD.
- Standardized language and accurate animal models are crucial for advancing DMD research.
Outlook:
- Future DMD treatments may emerge from cell and gene therapies.
- Improved communication and terminology are essential for multidisciplinary collaboration.
- The development of 'mouse doctors' is needed to bridge the gap between animal models and human clinical studies.